A newspaper report warns New Zealanders to brace for another round of invasive surgery after a recall of more hip implants.
According to The Dominion Post, Smith & Nephew R3 hip implants were recalled after unusually high rates of replacement surgery were required in Australia and the United Kingdom.
The report mentions a similar recall of DePuy all-metal hip implants from 2010. ...
continue reading...
A story in the Spring, 2012, issue of The Trial Lawyer magazine takes a look at the flaws in the federal approval process that allow dangerous transvaginal mesh kits to be implanted in women, with disastrous results.
The article is called “Transvaginal Pelvic Organ Prolapse Kits: The Chronicle of Failure.” It describes a system in which representatives of medical device companies frequent the offices of OB/GYNs and surgeons, urging them to ...
continue reading...Even as Johnson & Johnson has announced its intention to stop selling vaginal mesh implants, at least one other company intends to continue marketing them despite reports that the devices are severely injuring thousands of patients.
A Bloomberg report quotes Blaine Davis, Endo Health Solutions senior vice-president for corporate affairs, as saying: “As a company, we’re very committed to these categories. We are actually investing behind these products.”
Davis said the company, ...
continue reading...Johnson & Johnson has requested that the U.S. Food and Drug Administration allow the company 120 days to take four types of vaginal mesh implants off the market, despite widespread complaints that the devices are causing severe injuries for women who receive them.
Johnson & Johnson said in a statement that the action is not technically a recall.
Vaginal mesh implants are used to treat urinary incontinence and pelvic organ prolapse, which occurs when muscles are weakened – ...
continue reading...Johnson & Johnson has agreed to stop selling four types of vaginal mesh implants in response to mesh lawsuits from more than 600 women who claim the devices injured them.
According to Bloomberg, the company informed a federal judge in West Virginia that it intends to stop “commercializing” the implants. Bloomberg quotes a spokesman for Johnson & Johnson’s Ethicon unit as saying that sales of the devices will ...
continue reading...
